Sign In
Free Newsletter
Ritedose CEO turns childhood passion into pharma powerhouse
From a small-town childhood garden to leading Ritedose, CEO Jody Chastain combines passion for science and business to grow a pharma powerhouse.
Ritedose expands portfolio with new FDA-approved antibiotic
The Ritedose Corp. has received FDA approval to manufacture a new inhalation antibiotic, strengthening its U.S. production and sterile drug portfolio.
Ritedose opens new logistics facility in Columbia
Ritedose opens a $81M distribution facility in Columbia, expanding capacity to over 2B doses annually and creating 100 new life sciences jobs.
Ritedose gets FDA approval for COPD inhalation drug
Ritedose secures FDA approval for its formoterol inhalation solution, expanding COPD treatment options and strengthening its role in respiratory care.
